Lumobiotics careers

Lumobiotics develops light-controllable peptide drugs as safe cytolytic agents for treatment of solid cancers. Our peptide therapeutics are modified by photoisomerizable building blocks that can toggle between inactive and active forms. Biological activity is switched “on” with non-thermal red light irradiation in the site of tumors, avoiding side-effects in the healthy tissues. Unique MOA of membrane-active peptides avoids resistance development and activates innate immune system.